Overcoming CPT-11 resistance by using a biscoclaurine alkaloid, cepharanthine, to modulate plasma trans-membrane potentialKenjiro Aogi, Toshiwo Andoh, Ryungsa Kim et al.|International Journal of Cancer|1997Cited by 16